Abstract
This chapter deals with the marine biopharmaceuticals in the pipeline i.e.
year-wise number of approved marine drugs during the period 1969-2021 and their
clinical uses; approved and marketed drugs up to 2021; marine biota-derived drug
candidates under the different phases of clinical trials up to 2021; and marine
biotaderived clinical level compounds against SARS-CoV-2.
Keywords: Marine biopharmaceuticals in the pipeline, Year-wise approved marine drugs, Clinical uses of approved marine drugs, Marketed marine drugs up to 2021, and clinically tested marine compounds against SARS-CoV-2.
About this chapter
Cite this chapter as:
Santhanam Ramesh, Ramasamy Santhanam, Veintramuthu Sankar ;Marine Biopharmaceuticals in Pipeline, Marine Biopharmaceuticals: Scope and Prospects (2024) 1: 315. https://doi.org/10.2174/9789815196474124010014
DOI https://doi.org/10.2174/9789815196474124010014 |
Publisher Name Bentham Science Publisher |